Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Frontini

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, R Labianca, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trialC Gridelli, S Cigolari, C Gallo, et al.
Anticancer Research|May 16, 2000
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literatureC Gridelli, L Frontini, E Barletta, et al.
British Journal of Cancer|January 5, 2001
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 studyC Gridelli, L Manzione, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R Labianca, V Catalano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancerS Cascinu, R R Silva, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract CancerS Cascinu, R Labianca, P Alessandroni, et al.
Tumori|January 1, 1996
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancerL Frontini, P Candido, M T Cattaneo, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, R Labianca, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trialC Gridelli, S Cigolari, C Gallo, et al.
Anticancer Research|May 16, 2000
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literatureC Gridelli, L Frontini, E Barletta, et al.
British Journal of Cancer|January 5, 2001
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 studyC Gridelli, L Manzione, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R Labianca, V Catalano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancerS Cascinu, R R Silva, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract CancerS Cascinu, R Labianca, P Alessandroni, et al.
Tumori|January 1, 1996
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancerL Frontini, P Candido, M T Cattaneo, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Pageof 7